share_log

Avalo Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Steven Boyd(4.99%),Armistice Capital, LLC(4.7%)

Avalo Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Steven Boyd(4.99%),Armistice Capital, LLC(4.7%)

SEC announcement ·  2023/06/27 18:02
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息